OpenAlex
PricingAboutJobs
Log inGet started
Work

Peroxisome proliferator-activated receptor-?: therapeutic target for diseases beyond diabetes: quo vadis?

HTML

Year: 2004
Type: review
Source: Expert Opinion on Investigational Drugs
DOI: 10.1517/13543784.13.3.215
Author: Harrihar A Pershadsingh
Institution: Kern Medical Center
Language: English

Topic: Peroxisome Proliferator-Activated Receptors
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: PPARγ, thiazolidinediones, PPARγ agonists, insulin resistance, diabetes complications, atherosclerosis, coronary restenosis, psoriasis, ulcerative colitis, multiple sclerosis, asthma, atopic dermatitis, angiotensin receptor blockers, cardiovascular risk factors, anti-inflammatory activity, immunomodulation, rosiglitazone, pioglitazone, autoimmune disease, atopic diseases
SDG: Good health and well-being

Open Access status: closed

Funder: National Institute of Arthritis and Musculoskeletal and Skin Diseases
Awards: G2993714625, NOVEL THERAPEUTIC APPROACH TO PSORIASIS
OpenAlex ID: W2156336479
FWCI: 1.174
Cites: 121
Cited by: 92
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security